Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Tivantinib |
| Trade Name | |
| Synonyms | ARQ197|ARQ 197|ARQ-197 |
| Drug Descriptions |
Tivantinib (ARQ197) inhibits MET and may have antimitotic activity, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (PMID: 29924867, PMID: 28246274). |
| DrugClasses | MET Inhibitor 59 |
| CAS Registry Number | 905854-02-6 |
| NCIT ID | C62437 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Afatinib + Tivantinib | Afatinib Tivantinib | 0 | 0 |
| Bevacizumab + Tivantinib | Bevacizumab Tivantinib | 0 | 1 |
| Cetuximab + Tivantinib | Cetuximab Tivantinib | 0 | 0 |
| Pegfilgrastim + Tivantinib + Topotecan | Pegfilgrastim Tivantinib Topotecan | 0 | 1 |
| Temsirolimus + Tivantinib | Temsirolimus Tivantinib | 0 | 1 |
| Tivantinib | Tivantinib | 0 | 3 |